Stay updated on Helix BioPharma Press Releases
Sign up to get notified when there's something new on the Helix BioPharma Press Releases page.
Latest updates to the Helix BioPharma Press Releases page
- Check6 days agoChange DetectedThe website has added new sections for About Us, News, and Investor, while removing the Team, Technology, and Investors sections.SummaryDifference6%
- Check13 days agoChange DetectedHelix BioPharma Corp. has made significant updates, including the appointment of James B. Murphy as CFO, multiple asset purchase agreements to enhance its oncology portfolio, and the announcement of fiscal 2024 year-end results, while several older blog posts and presentations have been removed from the site.SummaryDifference100%
- Check20 days agoChange DetectedHelix BioPharma Corp. has added several new presentations and abstracts from 2017 to 2023, while notable deletions include the appointment of a new CFO and multiple asset purchase agreements related to their immune-oncology portfolio.SummaryDifference100%
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedHelix BioPharma Corp. has appointed James B. Murphy as Chief Financial Officer and amended acquisition agreements to finalize share consideration ahead of potential financing.SummaryDifference93%
- Check42 days agoChange DetectedHelix Biopharma Corp. has entered into an asset purchase agreement to acquire an oral chemotherapy compound, marking a significant development in its portfolio, while previous announcements regarding share consolidation and executive resignations have been removed.SummaryDifference23%
- Check49 days agoChange DetectedHelix Biopharma Corp. has entered into an asset purchase agreement to acquire an oral immune checkpoint inhibitor, expanding its immune-oncology portfolio, while the announcement regarding the grant of stock options has been removed.SummaryDifference24%
Stay in the know with updates to Helix BioPharma Press Releases
Enter your email address, and we'll notify you when there's something new on the Helix BioPharma Press Releases page.